Greylin Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $6.29M | Sell |
6,945
-480
| -6% | -$384K | 1.05% | 18 |
|
|
2024
Q1 | $5.78M | Sell |
7,425
-1,050
| -12% | -$747K | 0.93% | 21 |
|
|
2023
Q4 | $4.94M | Sell |
8,475
-325
| -4% | -$190K | 0.85% | 23 |
|
|
2023
Q3 | $4.73M | Sell |
8,800
-5,585
| -39% | -$2.88M | 0.85% | 22 |
|
|
2023
Q2 | $6.75M | Sell |
14,385
-150
| -1% | -$62.9K | 1.22% | 17 |
|
|
2023
Q1 | $4.99M | Hold |
14,535
| – | – | 0.91% | 24 |
|
|
2022
Q4 | $5.32M | Sell |
14,535
-90
| -0.6% | -$31.9K | 0.98% | 22 |
|
|
2022
Q3 | $4.73M | Sell |
14,625
-2,315
| -14% | -$733K | 0.98% | 22 |
|
|
2022
Q2 | $5.49M | Sell |
16,940
-220
| -1% | -$66K | 1.06% | 20 |
|
|
2022
Q1 | $4.91M | Hold |
17,160
| – | – | 0.84% | 24 |
|
|
2021
Q4 | $4.74M | Hold |
17,160
| – | – | 0.89% | 24 |
|
|
2021
Q3 | $3.96M | Buy |
17,160
+50
| +0.3% | +$12.3K | 0.81% | 24 |
|
|
2021
Q2 | $3.93M | Sell |
17,110
-70
| -0.4% | -$14.1K | 0.76% | 26 |
|
|
2021
Q1 | $3.21M | Sell |
17,180
-250
| -1% | -$48.9K | 0.67% | 28 |
|
|
2020
Q4 | $2.94M | Sell |
17,430
-150
| -0.9% | -$22.4K | 0.69% | 27 |
|
|
2020
Q3 | $2.6M | Sell |
17,580
-960
| -5% | -$149K | 0.69% | 25 |
|
|
2020
Q2 | $3.04M | Sell |
18,540
-820
| -4% | -$126K | 0.86% | 20 |
|
|
2020
Q1 | $2.69M | Sell |
19,360
-100
| -0.5% | -$13.7K | 0.84% | 21 |
|
|
2019
Q4 | $2.56M | Sell |
19,460
-450
| -2% | -$52.2K | 0.56% | 27 |
|
|
2019
Q3 | $2.23M | Hold |
19,910
| – | – | 0.53% | 29 |
|
|
2019
Q2 | $2.21M | Sell |
19,910
-2,760
| -12% | -$325K | 0.5% | 30 |
|
|
2019
Q1 | $2.94M | Sell |
22,670
-2,970
| -12% | -$361K | 0.66% | 25 |
|
|
2018
Q4 | $2.97M | Sell |
25,640
-575
| -2% | -$64.2K | 0.71% | 24 |
|
|
2018
Q3 | $2.81M | Sell |
26,215
-1,000
| -4% | -$100K | 0.61% | 26 |
|
|
2018
Q2 | $2.32M | Hold |
27,215
| – | – | 0.5% | 33 |
|
|
2018
Q1 | $2.11M | Buy |
27,215
+200
| +0.7% | +$16.1K | 0.46% | 31 |
|
|
2017
Q4 | $2.28M | Hold |
27,015
| – | – | 0.49% | 30 |
|
|
2017
Q3 | $2.31M | Sell |
27,015
-25
| -0.1% | -$2.05K | 0.53% | 27 |
|
|
2017
Q2 | $2.23M | Hold |
27,040
| – | – | 0.51% | 27 |
|
|
2017
Q1 | $2.27M | Hold |
27,040
| – | – | 0.53% | 22 |
|
|
2016
Q4 | $1.99M | Sell |
27,040
-1,400
| -5% | -$104K | 0.48% | 26 |
|
|
2016
Q3 | $2.28M | Sell |
28,440
-1,350
| -5% | -$108K | 0.57% | 24 |
|
|
2016
Q2 | $2.35M | Sell |
29,790
-225
| -0.7% | -$16.9K | 0.58% | 24 |
|
|
2016
Q1 | $2.16M | Sell |
30,015
-500
| -2% | -$37.8K | 0.56% | 23 |
|
|
2015
Q4 | $2.57M | Sell |
30,515
-3,250
| -10% | -$270K | 0.69% | 22 |
|
|
2015
Q3 | $2.83M | Sell |
33,765
-500
| -1% | -$42.2K | 0.78% | 20 |
|
|
2015
Q2 | $2.86M | Sell |
34,265
-250
| -0.7% | -$19K | 0.72% | 20 |
|
|
2015
Q1 | $2.38M | Hold |
34,515
| – | – | 0.57% | 22 |
|
|
2014
Q4 | $2.38M | Sell |
34,515
-420
| -1% | -$28.4K | 0.56% | 23 |
|
|
2014
Q3 | $2.27M | Sell |
34,935
-375
| -1% | -$23.7K | 0.54% | 23 |
|
|
2014
Q2 | $2.19M | Sell |
35,310
-5,475
| -13% | -$327K | 0.53% | 23 |
|
|
2014
Q1 | $2.4M | Sell |
40,785
-17,100
| -30% | -$954K | 0.58% | 21 |
|
|
2013
Q4 | $2.95M | Sell |
57,885
-20,325
| -26% | -$1.02M | 0.73% | 21 |
|
|
2013
Q3 | $3.94M | Sell |
78,210
-2,650
| -3% | -$139K | 2% | 13 |
|
|
2013
Q2 | $3.97M | Buy |
+80,860
| New | +$4.4M | 1.27% | 16 |
|
Other funds holding LLY
Greylin Investment Management's LLY Position: Q2 2024 in Review
Greylin Investment Management reduced its Eli Lilly (LLY) stake by 6.5% in Q2 2024, selling an estimated $384K and leaving 6,945 shares worth $6.29M. The position accounts for 1.05% of the portfolio, ranked #18.
Greylin Investment Management first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.75M in Q2 2023. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- Greylin Investment Management held 6,945 shares of Eli Lilly worth $6.29M as of Q2 2024.
- Greylin Investment Management sold 480 Eli Lilly shares in Q2 2024, an estimated $384K.
- Eli Lilly made up 1.05% of Greylin Investment Management's portfolio in Q2 2024, its #18 holding.
- Greylin Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
- Greylin Investment Management's Eli Lilly position peaked at $6.75M in Q2 2023.
- 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.